Celyad to Present Updates on CYAD-01 at the American Association for Cancer Research (AACR) Annual Meeting 2018

Celyad to Present Updates on CYAD-01 at the American Association for Cancer Research (AACR) Annual Meeting 2018

Celyad Reports 2017 Financial and Operating Results and Expected Key Milestones for 2018

Celyad Reports 2017 Financial and Operating Results and Expected Key Milestones for 2018

Celyad to Host Key Opinion Leader Meeting on CAR-T Therapy for the Treatment of Blood Cancers

Celyad to Host Key Opinion Leader Meeting on CAR-T Therapy for the Treatment of Blood Cancers

Celyad Provides Clinical Update and Strategic Outlook for 2018

Celyad Provides Clinical Update and Strategic Outlook for 2018

Discover our news

Upcoming events

May 1-3, 2018

PEGS

May 2-5, 2018

ISCT 2018 Montreal Annual Meeting

May 18-20, 2018

World Cancer Progress

Discover all events

Press material

Dear Journalists,
Please find here all information background and material for your articles.
For any media request, please refer to the contacts below.
Join our press list
Press kit

Press kit

1.5 Mo

a

Press contacts

Celyad

Nicolas Van Hoecke Director, Investor Relations & Communications

+32 (0)10 39 41 84

LifeSci Advisors

Matt Middleman

NewCap (France)

Nicolas Merigeau, Pierre Laurent

+ 33(0)1 44 71 94 94

Comfi (Belgium)

Gunther De Backer, Sabine Leclercq

+32(0) 2 290 90 91